Search results
Alecensa approved as first and only anaplastic lymphoma kinase inhibitor for non-small cell lung...
Medical Xpress· 5 days agoThe U.S. Food and Drug Administration has approved Genentech's Alecensa (alectinib) as adjuvant...
Utah woman lost 100 pounds in 1 year: Here's how
KSL Salt Lake City· 3 days agoThis story is sponsored by Health Utah. If losing weight takes forever but you gain weight seemingly overnight, you might actually have health problems...
ESR1-Driven Resistance to CDK4/6 Inhibitors in Breast Cancer Thwarted by SERDs
MedPage Today· 4 days agoMutations in ESR1 do not appear to confer breast cancer resistance to cyclin-dependent kinase...
What Can Cause a Rash Around the Eyes?
Verywell Health via Yahoo News· 6 days agoMany conditions can cause a rash around the eyes, from infections to dermatological conditions like dermatitis or psoriasis. Here’s what you need to...
GDR Labs Liponine Reviews – The Latest Customer Results Reported!
Greeley Tribune· 6 hours agoMore than 114 million people in America struggle with Type 2 diabetes, and the number is equally...
Challenging Old Theories: Innovative Microscopy Exposes New Alzheimer’s Treatment Pathways
SciTechDaily· 1 day agoResearchers at UC San Diego have utilized advanced imaging techniques to explore the metabolic...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
WTNH-TV New Haven· 4 days agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced...
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4%
ETF DAILY NEWS· 5 days agoCogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) shares rose 4% during trading on Monday . The stock traded as high as $7.04 and last traded at $6.98. Approximately 288,808 shares traded ...
Alectinib Approved for ALK-Positive Adjuvant NSCLC
Medscape· 7 days agoThe approval makes alectinib the first ALK inhibitor approved for early-stage NSCLC.
HanxBio announces the publication of a research paper in Scientific Reports on preclinical...
FOX 59 Indianapolis· 6 days agoHanxBio today announced that it has published a research article titled "Narazaciclib, a novel...
